The Diabetes Care Devices Market is expected to grow at a CAGR of 6.7% from 2021 to reach $31.9 billion by 2028. Increasing prevalence of diabetes, unhealthy lifestyle, product innovations in diabetes care, rising obesity rate, and development of new insulin delivery systems are the key factors driving steady growth of the global diabetes care devices market.
COVID-19 Impact Assessment
The COVID-19 pandemic severely affected the diabetic care device market's growth. COVID-19 infected patients saw their blood glucose levels rise. The stress of infection and the usage of steroids for the COVID-19 treatment contributed to the rise in blood glucose levels, resulting in a higher number of patients. This undoubtedly created opportunities for big players in the market. Due to the rising prevalence of diabetes, many players launched new advanced diabetes care devices and signed collaborations and agreements for diabetes care devices. However, due to lockdowns and travel restrictions, the market experienced a supply chain disruption, resulting in a scarcity of diabetes care devices, but this had only a transitory impact on the diabetic care devices market.
Click here to: Get Free Request Sample Copy of this report
Increasing Prevalence of Diabetes
Diabetes is a chronic condition in which the pancreas does not make enough insulin or efficiently utilizes it to regulate body sugar. Diabetes was the tenth largest cause of mortality in 2019, with an estimated 1.5 million fatalities caused directly by the disease. Type 2 diabetes (also known as non-insulin-dependent diabetes or adult-onset diabetes) is caused by the body's poor utilization of insulin. Type 2 diabetes affects more than 95% of patients with diabetes. Excess body weight and physical inactivity are the main causes of diabetes.
Diabetes is becoming more common worldwide, accounting for 6.7 million deaths in 2021 (Source: International Diabetes Federation). The enormous increase in the diabetes population is mostly due to increased obesity rates worldwide and sedentary lifestyles characterized by poor diets and decreased physical activity. In low- and middle-income nations, prevalence has been increasing faster.
Rising Obesity Rate and Unhealthy and Sedentary Lifestyle
The expanding urbanization and motorization have decreased the degrees of actual work. The WHO indicates that more than 60% of the worldwide populace isn't adequately dynamic. The World Wellbeing Organization expresses that active work is one of the life-supporting elements, and consequently, at whatever stage in life, it secures against any ongoing medical conditions, including many structures of cardiovascular illnesses or diabetes. The danger of type 2 diabetes ascends with expanding body weight at all ages. The pervasiveness of type 2 diabetes is three to multiple times higher in those impacted by corpulence than in ordinary weight and is more probable in those with a weight file (BMI) more prominent than 35 kg/m 2.
Unhealthy way of living that includes smoking and terrible eating routines expands the danger of type-2 diabetes. Shift work, particularly night shift work, has been related to more danger of type-2 diabetes. Smoking is a significant danger factor that brings about higher possibilities of creating diabetes than non-smokers. The danger of diabetes increments with the number of cigarettes smoked each day.
Key Findings in the Global Diabetes Care Devices Market Study:
Diabetes Monitoring Devices Segment is Estimated to Register Fastest Growth in the Diabetes Care Devices Market by 2028
The increased adoption of test strips and self-monitoring blood glucose meters and increasing demand for continuous glucose monitoring with rising awareness of the disease in developing countries are major reasons leading to the growth of the diabetes monitoring devices segment.
Asia-Pacific: Fastest Growing Geographical Market
North America is estimated to command the largest share of the global diabetes care devices market in 2021, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia-Pacific will be the fastest growing market due to, increasing diabetic population, new product launches and distribution strategies undertaken by leading companies, and government initiatives to increase awareness about self-diabetes management.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past four years . The key players profiled in the global diabetes care devices market report are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), LifeScan IP Holdings, LLC (U.S.), Medtronic PLC (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), and Sanofi AS (France), Tandem Diabetes Care, Inc. (U.S.), Insulate Corporation (U.S.) and DexCom, Inc. (U.S.).
Scope of the Report:
Diabetes Care Devices Market, by Type
Diabetes Care Devices Market, by Geography
Key Questions Answered in The Report:
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Prevalence of Diabetes
4.2.2. Rising Obesity and Prevalence of Disease-Causing Lifestyle
4.2.3. Product Innovations in Diabetes Care
4.2.4. Development of Advanced Insulin Delivery Systems
4.3. Restraints
4.3.1. Insurance Coverage and Reimbursement Scenarios
4.3.2. Product Recalls
4.4. Opportunities
4.4.1. Growing Demand for Non-Invasive Glucose Monitoring Devices
4.5. Challenges
4.5.1. Undiagnosed Diabetes Among Population
4.5.2. Cost of Diabetes Care Devices
4.5.3. Limited Accessibility for Diabetes Care Devices in Low- and Middle-Income Countries
4.6. Regulatory Analysis
4.6.1. North America
4.6.2. Europe
4.6.3. Asia-Pacific
4.7. Impact Assessment of Covid-19 Pandemic on Diabetes Care Devices Market
4.8. Diabetes Patients Population Analysis
4.8.1. Global Diabetes Prevalence
4.8.2. Diabetes Patient Analysis – U.S.
4.8.2.1. Number of Patients - Type 1 Vs Type II (U.S.)
4.8.2.2. Number of Patients Using Monitoring Devices (U.S.)
4.8.2.3. Number of Patients on Insulin Delivery Devices (U.S.)
4.9. Next-Generation Technologies and Solutions for Diabetes Management
4.9.1. Smart Insulin Pens
4.9.2. Closed-Loop Systems
4.9.3. Next Generation CGM Sensors
5. Global Diabetes Care Devices Market, by Type
5.1. Introduction
5.2. Diabetes Monitoring Devices
5.2.1. Test Strips
5.2.2. Continuous Blood Glucose Monitoring Devices
5.2.3. Self-Monitoring Blood Glucose Meters
5.2.4. Hemoglobin A1c Testing Kits
5.2.5. Lancets
5.3. Insulin Delivery Devices
5.3.1. Insulin Pens
5.3.2. Insulin Syringes
5.3.3. Insulin Pumps
5.3.4. Insulin Jet Injectors
6. Diabetes Care Devices Market, by Geography
6.1. Introduction
6.2. North America
6.2.1. U.S.
6.2.2. Canada
6.3. Europe
6.3.1. Germany
6.3.2. France
6.3.3. U.K.
6.3.4. Italy
6.3.5. Spain
6.3.6. Rest of Europe (ROE)
6.4. Asia-Pacific
6.4.1. Japan
6.4.2. China
6.4.3. India
6.4.4. Rest of Asia-Pacific
6.5. Latin America
6.6. Middle East & Africa
7. Competitive Landscape
7.1. Introduction
7.2. Key Growth Strategies
7.3. Competitive Benchmarking
7.4. Market Share Analysis (2020)
7.4.1. Abbott Laboratories (U.S.)
7.4.2. Medtronic PLC (Ireland)
7.4.3. Dexcom, Inc. (U.S.)
7.4.4. F. Hoffmann-La Roche Ltd (Switzerland)
7.5. Diabetes Care Devices Revenue Analysis (2016-2020)
7.5.1. Abbott Laboratories
7.5.2. Medtronic PLC
7.5.3. DexCom, Inc.
7.5.4. F. Hoffmann-La Roche Ltd
7.5.5. LifeScan IP Holdings, LLC
7.5.6. Becton, Dickinson and Company
7.5.7. Insulet Corporation
7.5.8. Novo Nordisk A/S
7.5.9. Tandem Diabetes Care, Inc.
7.5.10. Ypsomed AG
8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Business Overview
8.1.2. Financial Overview
8.1.3. Product Portfolio
8.1.4. Strategic Developments
8.2. Ascensia Diabetes Care Holdings AG (A Part of PHC Holdings Corporation)
8.2.1. Business Overview
8.2.2. Financial Overview
8.2.3. Product Portfolio
8.2.4. Strategic Developments
8.3. Becton, Dickinson and Company
8.3.1. Business Overview
8.3.2. Financial Overview
8.3.3. Product Portfolio
8.4. DexCom, Inc.
8.4.1. Business Overview
8.4.2. Financial Overview
8.4.3. Product Portfolio
8.4.4. Strategic Developments
8.5. F. Hoffmann-La Roche Ltd.
8.5.1. Business Overview
8.5.2. Financialoverview
8.5.3. Product Portfolio
8.5.4. Strategic Developments
8.6. Insulet Corporation
8.6.1. Business Overview
8.6.2. Financial Overview
8.6.3. Product Portfolio
8.6.4. Strategic Developments
8.7. LifeScan IP Holdings, LLC (Subsidiary of Platinum Equity, LLC (U.S.))
8.7.1. Business Overview
8.7.2. Product Portfolio
8.7.3. Strategic Developments
8.8. Medtronic PLC
8.8.1. Business Overview
8.8.2. Financial Overview
8.8.3. Product Portfolio
8.8.4. Strategic Developments
8.9. Novo Nordisk A/S
8.9.1. Business Overview
8.9.2. Financial Overview
8.9.3. Product Portfolio
8.9.4. Strategic Developments
8.10. Sanofi AS
8.10.1. Business Overview
8.10.2. Financial Overview
8.10.3. Product Portfolio
8.10.4. Strategic Developments
8.11. Tandem Diabetes Care, Inc.
8.11.1. Business Overview
8.11.2. Financial Overview
8.11.3. Product Portfolio
8.11.4. Strategic Developments
8.12. Terumo Corporation
8.12.1. Business Overview
8.12.2. Financial Overview
8.12.3. Product Portfolio
8.12.4. Strategic Developments
8.13. Ypsomed AG
8.13.1. Business Overview
8.13.2. Financial Overview
8.13.3. Product Portfolio
8.13.4. Strategic Developments
9. Appendix
9.1. Questionnaire
9.2. Available Customization
List of Tables
Table 1 Global Diabetes Care Devices Market Drivers: Impact Analysis (2021–2028)
Table 2 Number of People With Diabetes Among Aged 20-79 Years, 2021 Vs 2030 Vs 2045 (in Million)
Table 3 Product Innovations by Companies
Table 4 Non-Invasive Glucose Monitoring Devices Comparison
Table 5 Some of the Glucose Monitoring Devices Under Development
Table 6 Examples of Approved Non-Invasive Glucose Monitoring Devices
Table 7 Proportion and Number of Undiagnosed People (20-79 Years) Living With Diabetes, 2021
Table 8 Price Estimates for SMBG and CGM (in USD)
Table 9 Replacement Frequency for Glucose Self-Monitoring Commodities in High Income Countries and Lower Middle Income Countries
Table 10 Classification of Diabetes Care Devices
Table 11 Global Prevalence of Diabetes, by Region (2021)
Table 12 Smart Insulin Pens in the Market
Table 13 Commercially Available Smart Caps
Table 14 Current FDA-approved CGM Devices
Table 15 Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 16 Global Diabetes Monitoring Devices Market Size, by Type, 2019-2028 (USD Million)
Table 17 Global Diabetes Monitoring Devices Market Size, by Country/Region, 2019–2028 (USD Million)
Table 18 Global Test Strips Market Size, by Country/Region, 2019–2028 (USD Million)
Table 19 Global Continuous Blood Glucose Monitoring Devices Market Size, by Country/Region, 2019–2028 (USD Million)
Table 20 Global Self-Monitoring Blood Glucose Meters Market Size, by Country/Region, 2019–2028 (USD Million)
Table 21 Global Hemoglobin A1c Testing Kits Market Size, by Country/Region, 2019–2028 (USD Million)
Table 22 Global Lancets Market Size, by Country/Region, 2019–2028 (USD Million)
Table 23 Global Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 24 Global Insulin Delivery Devices Market Size, by Country/Region, 2019–2028
(USD Million)
Table 25 Global Insulin Pens Market Size, by Country/Region, 2019–2028 (USD Million)
Table 26 Global Insulin Syringes Market Size, by Country/Region, 2019–2028 (USD Million)
Table 27 Global Insulin Pumps Market Size, by Country/Region, 2019–2028 (USD Million)
Table 28 Global Insulin Jet Injectors Market Size, by Country/Region, 2019–2028 (USD Million)
Table 29 Global Diabetes Care Devices Market Size, by Country/Region, 2019–2028 (USD Million)
Table 30 North America: Diabetes Care Devices Market Size, by Country, 2019–2028 (USD Million)
Table 31 North America: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 32 North America: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 33 North America: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 34 U.S.: Diabetes Indicators
Table 35 U.S.: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 36 U.S.: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 37 U.S.: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 38 Canada: Diabetes Statistics
Table 39 Canada: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 40 Canada: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 41 Canada: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 42 Europe: Diabetes Care Devices Market Size, by Country/Region, 2019–2028 (USD Million)
Table 43 Europe: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 44 Europe: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 45 Europe: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 46 Germany: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 47 Germany: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 48 Germany: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 49 France: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 50 France: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 51 France: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 52 U.K.: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 53 U.K.: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 54 U.K.: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 55 Italy: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 56 Italy: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 57 Italy: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 58 Obesity Prevalence in Spain (2019)
Table 59 Prevalence of Type 1 Diabetes in Spain (2021)
Table 60 Spain: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 61 Spain: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 62 Spain: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 63 ROE: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 64 ROE: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 65 ROE: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 66 Asia-Pacific: Diabetes Care Devices Market Size, by Country, 2019–2028 (USD Million)
Table 67 Asia-Pacific: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 68 Asia-Pacific: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 69 Asia-Pacific: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 70 Japan: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 71 Japan: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 72 Japan: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 73 China: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 74 China: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 75 China: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 76 India: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 77 India: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 78 India: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 79 Diabetes Prevelance in Asian Countries (% Population Ages 20-79) (2010-2019)
Table 80 ROAPAC: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 81 ROAPAC: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 82 ROAPAC: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 83 Latin America: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 84 Latin America: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 85 Latin America: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 86 Number of Adults (20-79 Years) With Diabetes in Mea Countries (2019 & 2021)
Table 87 Middle East & Africa: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million)
Table 88 Middle East & Africa: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million)
Table 89 Middle East & Africa: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million)
Table 91 Abbott Laboratories: Diabetes Care Devices Revenue (USD Million) (2017-2020)
Table 92 Medtronic PLC: Diabetes Care Devices Revenue (USD Million) (2016-2020)
Table 93 DexCom, Inc.: Diabetes Care Devices Revenue (USD Million) (2016-2020)
Table 94 F. Hoffmann-La Roche Ltd: Diabetes Care Devices Revenue (USD Million) (2016-2020)
Table 95 Lifescan IP Holdings LLC.: Diabetes Care Devices Revenue (USD Million) (2016-2018)
Table 96 Becton, Dickinson and Company: Diabetes Care Devices Revenue (USD Million) (2016-2021)
Table 97 Insulet Corporation: Diabetes Care Devices Revenue (USD Million) (2016-2020)
Table 98 Novo Nordisk A/S: Diabetes Care Devices Revenue (USD Million) (2016-2020)
Table 99 Tandem Diabetes Care, Inc.: Diabetes Care Devices Revenue (USD Million) (2016-2020)
Table 100 Ypsomed AG: Diabetes Care Devices Revenue (USD Million) (2016-2020)
List of Figures
Figure 1 Key Stakeholders
Figure 2 Research Process
Figure 3 Key Secondary Sources
Figure 4 Primary Research Techniques
Figure 5 Key Executives Interviewed
Figure 6 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 7 Market Size Estimation
Figure 8 Global Diabetes Care Devices Market, by Type, 2021 Vs. 2028 (USD Million)
Figure 9 Global Diabetes Care Devices Market, by Geography
Figure 10 Market Dynamics
Figure 11 Prevalence of Diabetes Across the World (in Million)
Figure 12 Evolution of Insulin Delivery Systems (2013–2020)
Figure 13 Diabetes Prevalence (2021 Vs 2030 Vs 2045)
Figure 14 U.S. Diabetes Patient Analysis
Figure 15 Diabetes Care Devices Market Size, by Type, 2021 Vs 2028 (USD Million)
Figure 16 Global Diabetes Care Devices Market Size, by Geography, 2021–2028 (USD Million)
Figure 17 North America: Diabetes Care Devices Market Snapshot
Figure 18 Prevalence of Diabetes in the U.S. (2000–2045)
Figure 19 Prevalence of Diabetes in Europe, by Country (2021)
Figure 20 Europe: Diabetes Care Devices Market Snapshot
Figure 21 Prevalence of Diabetes in Germany (2000-2030)
Figure 22 Prevalence of Diabetes in the U.K. (2000-2045)
Figure 23 Italy: Share of Population Aged 65 and Above (2010-2020)
Figure 24 Prevalence of Diabetes in Spain (2011-2045)
Figure 25 Prevalence Rate of Diabetes in Rest of Europe (2021 Vs 2030)
Figure 26 Asia-Pacific: Diabetes Care Devices Market Size Snapshot
Figure 27 Diabetes Prevalence in China (2017-2045)
Figure 28 Key Growth Strategies Adopted by Leading Players, 2018-2021
Figure 29 Diabetes Care Devices Market: Competitive Benchmarking
Figure 30 Diabetes Care Devices Market: Competitive Benchmarking by Geography
Figure 31 Market Share Analysis: Diabetes Care Devices, 2020
Figure 32 Abbott Laboratories: Financial Overview (2020)
Figure 33 PHC Holdings Corporation: Financial Overview (2020)
Figure 34 Becton, Dickinson and Company: Financial Overview (2021)
Figure 35 DexCom, Inc.: Financial Overview (2020)
Figure 36 F. Hoffmann-La Roche Ltd.: Financial Overview (2020)
Figure 37 Insulet Corporation: Financial Overview (2020)
Figure 38 Medtronic PLC: Financial Overview (2020)
Figure 39 Novo Nordisk A/S: Financial Overview (2020)
Figure 40 Sanofi: Financial Overview (2020)
Figure 41 Tandem Diabetes Care, Inc.: Financial Overview (2020)
Figure 42 Terumo Corporation: Financial Overview (2020)
Figure 43 Ypsomed AG: Financial Overview (2020)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Jan-2023
Published Date: Oct-2022
Published Date: Sep-2021
Published Date: Jun-2019
Published Date: Feb-2019
